|
1
|
Castleberry RP: Neuroblastoma. Eur J
Cancer. 33:1430–1438. 1997. View Article : Google Scholar
|
|
2
|
Maris JM: Recent advances in
neuroblastoma. N Engl J Med. 362:2202–2211. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Maris JM, Hogarty MD, Bagatell R and Cohn
SL: Neuroblastoma. Lancet. 369:2106–2120. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Brodeur GM: Neuroblastoma: biological
insights into a clinical enigma. Nat Rev Cancer. 3:203–216. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Weinstein JL, Katzenstein HM and Cohn SL:
Advances in the diagnosis and treatment of neuroblastoma.
Oncologist. 8:278–292. 2003. View Article : Google Scholar
|
|
6
|
Westermann F and Schwab M: Genetic
parameters of neuroblastomas. Cancer Lett. 184:127–147. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Becker J, Erdlenbruch B, Noskova I, et al:
Keratoepithelin suppresses the progression of experimental human
neuroblastomas. Cancer Res. 66:5314–5321. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Becker J, Pavlakovic H, Ludewig F, et al:
Neuroblastoma progression correlates with downregulation of the
lymphangiogenesis inhibitor sVEGFR-2. Clin Cancer Res.
16:1431–1441. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Becker J, Volland S, Noskova I, Schramm A,
Schweigerer LL and Wilting J: Keratoepithelin reverts the
suppression of tissue factor pathway inhibitor 2 by MYCN in human
neuroblastoma: a mechanism to inhibit invasion. Int J Oncol.
32:235–240. 2008.PubMed/NCBI
|
|
10
|
Volland S, Kugler W, Schweigerer L,
Wilting J and Becker J: Stanniocalcin 2 promotes invasion and is
associated with metastatic stages in neuroblastoma. Int J Cancer.
125:2049–2057. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Norgall S, Papoutsi M, Rossler J,
Schweigerer L, Wilting J and Weich HA: Elevated expression of
VEGFR-3 in lymphatic endothelial cells from lymphangiomas. BMC
Cancer. 7:1052007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Petrova TV, Makinen T, Makela TP, et al:
Lymphatic endothelial reprogramming of vascular endothelial cells
by the Prox-1 homeobox transcription factor. EMBO J. 21:4593–4599.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Podgrabinska S, Braun P, Velasco P, Kloos
B, Pepper MS and Skobe M: Molecular characterization of lymphatic
endothelial cells. Proc Natl Acad Sci USA. 99:16069–16074. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
D’Arcangelo G, Miao GG, Chen SC, Soares
HD, Morgan JI and Curran T: A protein related to extracellular
matrix proteins deleted in the mouse mutant reeler. Nature.
374:719–723. 1995.
|
|
15
|
Kohno T and Hattori M: Re-evaluation of
protease activity of reelin. Biol Pharm Bull. 33:1047–1049. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Quattrocchi CC, Wannenes F, Persico AM, et
al: Reelin is a serine protease of the extracellular matrix. J Biol
Chem. 277:303–309. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
D’Arcangelo G, Homayouni R, Keshvara L,
Rice DS, Sheldon M and Curran T: Reelin is a ligand for lipoprotein
receptors. Neuron. 24:471–479. 1999.
|
|
18
|
Benhayon D, Magdaleno S and Curran T:
Binding of purified Reelin to ApoER2 and VLDLR mediates tyrosine
phosphorylation of Disabled-1. Brain Res Mol Brain Res. 112:33–45.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hiesberger T, Trommsdorff M, Howell BW, et
al: Direct binding of Reelin to VLDL receptor and ApoE receptor 2
induces tyrosine phosphorylation of disabled-1 and modulates tau
phosphorylation. Neuron. 24:481–489. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Howell BW, Hawkes R, Soriano P and Cooper
JA: Neuronal position in the developing brain is regulated by mouse
disabled-1. Nature. 389:733–737. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Strasser V, Fasching D, Hauser C, et al:
Receptor clustering is involved in Reelin signaling. Mol Cell Biol.
24:1378–1386. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Trommsdorff M, Gotthardt M, Hiesberger T,
et al: Reeler/Disabled-like disruption of neuronal migration in
knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell.
97:689–701. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dulabon L, Olson EC, Taglienti MG, et al:
Reelin binds alpha-3beta1 integrin and inhibits neuronal migration.
Neuron. 27:33–44. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hoe HS, Lee KJ, Carney RS, et al:
Interaction of reelin with amyloid precursor protein promotes
neurite outgrowth. J Neurosci. 29:7459–7473. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yip YP, Kronstadt-O’Brien P, Capriotti C,
Cooper JA and Yip JW: Migration of sympathetic preganglionic
neurons in the spinal cord is regulated by Reelin-dependent Dab1
tyrosine phosphorylation and CrkL. J Comp Neurol. 502:635–643.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Evangelisti C, Florian MC, Massimi I, et
al: MiR-128 up-regulation inhibits Reelin and DCX expression and
reduces neuroblastoma cell motility and invasiveness. FASEB J.
23:4276–4287. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hughes M, Marsden HB and Palmer MK:
Histologic patterns of neuroblastoma related to prognosis and
clinical staging. Cancer. 34:1706–1711. 1974. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Peuchmaur M, d’Amore ES, Joshi VV, et al:
Revision of the International Neuroblastoma Pathology
Classification: confirmation of favorable and unfavorable
prognostic subsets in ganglioneuroblastoma, nodular. Cancer.
98:2274–2281. 2003. View Article : Google Scholar
|
|
29
|
Becker J, Wang B, Pavlakovic H, Buttler K
and Wilting J: Homeobox transcription factor Prox1 in sympathetic
ganglia of vertebrate embryos: correlation with human stage 4s
neuroblastoma. Pediatr Res. 68:112–117. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen Y, Kundakovic M, Agis-Balboa RC,
Pinna G and Grayson DR: Induction of the reelin promoter by
retinoic acid is mediated by Sp1. J Neurochem. 103:650–665. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pahlman S, Hoehner JC, Nanberg E, et al:
Differentiation and survival influences of growth factors in human
neuroblastoma. Eur J Cancer. 31A:453–458. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wilting J, Papoutsi M, Christ B, et al:
The transcription factor Prox1 is a marker for lymphatic
endothelial cells in normal and diseased human tissues. FASEB J.
16:1271–1273. 2002.PubMed/NCBI
|
|
33
|
Lagodny J, Juttner E, Kayser G, Niemeyer
CM and Rossler J: Lymphangiogenesis and its regulation in human
neuroblastoma. Biochem Biophys Res Commun. 352:571–577. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Falconer DS and Sierts-Roth U: Dreher, a
new gene of the waltzer-shaker group in the house mouse. Z Indukt
Abstamm Vererbungsl. 84:71–73. 1951.(In undetermined language).
|
|
35
|
Fatemi SH: Reelin mutations in mouse and
man: from reeler mouse to schizophrenia, mood disorders, autism and
lissencephaly. Mol Psychiatry. 6:129–133. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hourihane JO, Bennett CP, Chaudhuri R,
Robb SA and Martin ND: A sibship with a neuronal migration defect,
cerebellar hypoplasia and congenital lymphedema. Neuropediatrics.
24:43–46. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lorenzetto E, Panteri R, Marino R, Keller
F and Buffelli M: Impaired nerve regeneration in reeler mice after
peripheral nerve injury. Eur J Neurosci. 27:12–19. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Panteri R, Mey J, Zhelyaznik N, et al:
Reelin is transiently expressed in the peripheral nerve during
development and is upregulated following nerve crush. Mol Cell
Neurosci. 32:133–142. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Smalheiser NR, Costa E, Guidotti A, et al:
Expression of reelin in adult mammalian blood, liver, pituitary
pars intermedia, and adrenal chromaffin cells. Proc Natl Acad Sci
USA. 97:1281–1286. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kim DH, Iijima H, Goto K, et al: Human
apolipoprotein E receptor 2. A novel lipoprotein receptor of the
low density lipoprotein receptor family predominantly expressed in
brain. J Biol Chem. 271:8373–8380. 1996.PubMed/NCBI
|
|
41
|
Koch S, Strasser V, Hauser C, et al: A
secreted soluble form of ApoE receptor 2 acts as a
dominant-negative receptor and inhibits Reelin signaling. EMBO J.
21:5996–6004. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Brandes AA, Palmisano V, Pasetto LM, Basso
U and Monfardini S: High-dose chemotherapy with bone marrow rescue
for high-grade gliomas in adults. Cancer Invest. 19:41–48. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Brandes C, Novak S, Stockinger W, Herz J,
Schneider WJ and Nimpf J: Avian and murine LR8B and human
apolipoprotein E receptor 2: differentially spliced products from
corresponding genes. Genomics. 42:185–191. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kim DH, Magoori K, Inoue TR, et al:
Exon/intron organization, chromosome localization, alternative
splicing, and transcription units of the human apolipoprotein E
receptor 2 gene. J Biol Chem. 272:8498–8504. 1997. View Article : Google Scholar
|
|
45
|
Bock HH, Jossin Y, Liu P, et al:
Phosphatidylinositol 3-kinase interacts with the adaptor protein
Dab1 in response to Reelin signaling and is required for normal
cortical lamination. J Biol Chem. 278:38772–38779. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Thiele C: Neuroblastoma cell lines. Human
Cell Culture. 1. Masters J: Kluwer Academic Publishers; Lancaster:
pp. 21–53. 1998, View Article : Google Scholar
|
|
47
|
Zhao S and Frotscher M: Go or stop?
Divergent roles of Reelin in radial neuronal migration.
Neuroscientist. 16:421–434. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Meyer G and Goffinet AM: Prenatal
development of reelin-immunoreactive neurons in the human
neocortex. J Comp Neurol. 397:29–40. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Senturk A, Pfennig S, Weiss A, Burk K and
Acker-Palmer A: Ephrin Bs are essential components of the Reelin
pathway to regulate neuronal migration. Nature. 472:356–360. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Schmid RS, Jo R, Shelton S, Kreidberg JA
and Anton ES: Reelin, integrin and DAB1 interactions during
embryonic cerebral cortical development. Cereb Cortex.
15:1632–1636. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Sato N, Fukushima N, Chang R, Matsubayashi
H and Goggins M: Differential and epigenetic gene expression
profiling identifies frequent disruption of the RELN pathway in
pancreatic cancers. Gastroenterology. 130:548–565. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Perrone G, Vincenzi B, Zagami M, et al:
Reelin expression in human prostate cancer: a marker of tumor
aggressiveness based on correlation with grade. Mod Pathol.
20:344–351. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Seigel GM, Hackam AS, Ganguly A, Mandell
LM and Gonzalez-Fernandez F: Human embryonic and neuronal stem cell
markers in retinoblastoma. Mol Vis. 13:823–832. 2007.PubMed/NCBI
|
|
54
|
Wang Q, Lu J, Yang C, et al: CASK and its
target gene Reelin were co-upregulated in human esophageal
carcinoma. Cancer Lett. 179:71–77. 2002. View Article : Google Scholar : PubMed/NCBI
|
